0001144204-16-074142.txt : 20160105
0001144204-16-074142.hdr.sgml : 20160105
20160105173805
ACCESSION NUMBER: 0001144204-16-074142
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160101
FILED AS OF DATE: 20160105
DATE AS OF CHANGE: 20160105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fortress Biotech, Inc.
CENTRAL INDEX KEY: 0001429260
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205157386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 3 COLUMBUS CIRCLE
STREET 2: 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC
DATE OF NAME CHANGE: 20080310
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WEISS MICHAEL S
CENTRAL INDEX KEY: 0001038977
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35366
FILM NUMBER: 161324007
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
form476424_20160105053737-.xml
X0306
4
2016-01-01
0
0001429260
Fortress Biotech, Inc.
FBIO
0001038977
WEISS MICHAEL S
C/O FORTRESS BIOTECH, INC.
3 COLUMBUS CIRCLE
NEW YORK
NY
US 10019
1
1
1
0
Exec. VC - Strategic Dev.
Common Stock, par value $0.001
2016-01-01
4
A
0
510434
0
A
7448472
D
Options to purchase Common Stock
2.1
2023-12-19
Common Stock
30000
30000
D
Represents an award of restricted shares of the Issuer's common stock made pursuant to the Fortress Biotech, Inc. Long Term Incentive Plan.
One-third of the shares will vest on each of December 19, 2014, 2015 and 2016.
/s/ S. Halle Vakani, Attorney-in-Fact
2016-01-05